Global Induced Pluripotent Stem Cells (iPSCs) Market 2020 by Company, Regions, Type and Application, Forecast to 2025

  • receipt Report ID : 35680
  • calendar_today Published On: Sep, 2020
  • file_copy Pages: 156
  • list Pharmaceuticals and Healthcare
Buy @ $3500

Market Overview

The Induced Pluripotent Stem Cells (iPSCs) market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

The global Induced Pluripotent Stem Cells (iPSCs) market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 11.7%% in the forecast period of 2020 to 2025 and will expected to reach USD 129.1 million by 2025, from USD 83 million in 2019.

Market segmentation

Induced Pluripotent Stem Cells (iPSCs) market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

By Type, Induced Pluripotent Stem Cells (iPSCs) market has been segmented into:

Human iPSCs

Mouse iPSCs

By Application, Induced Pluripotent Stem Cells (iPSCs) has been segmented into:

Academic Research

Drug Development and Discovery

Toxicity Screening

Regenerative Medicine

Others

Regions and Countries Level Analysis

Regional analysis is another highly comprehensive part of the research and analysis study of the global Induced Pluripotent Stem Cells (iPSCs) market presented in the report. This section sheds light on the sales growth of different regional and country-level Induced Pluripotent Stem Cells (iPSCs) markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Induced Pluripotent Stem Cells (iPSCs) market.

The report offers in-depth assessment of the growth and other aspects of the Induced Pluripotent Stem Cells (iPSCs) market in important countries (regions), including:

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia and Italy)

Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)

South America (Brazil, Argentina, Colombia)

Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Competitive Landscape and Induced Pluripotent Stem Cells (iPSCs) Market Share Analysis

Induced Pluripotent Stem Cells (iPSCs) competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Induced Pluripotent Stem Cells (iPSCs) sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Induced Pluripotent Stem Cells (iPSCs) sales, revenue and market share for each player covered in this report.

The major players covered in Induced Pluripotent Stem Cells (iPSCs) are:

Fujifilm Holding Corporation (CDI)

ReproCELL

Astellas Pharma Inc

Ncardia

Cell Inspire Biotechnology

Sumitomo Dainippon Pharma

Pluricell Biotech

Fate Therapeutics, Inc

Among other players domestic and global, Induced Pluripotent Stem Cells (iPSCs) market share data is available for global, North America, Europe, Asia-Pacific, Middle East & Africa and South America separately. Our analysts understand competitive strengths and provide competitive analysis for each competitor separately.

Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

1 Induced Pluripotent Stem Cells (iPSCs) Market Overview

1.1 Product Overview and Scope of Induced Pluripotent Stem Cells (iPSCs)

1.2 Classification of Induced Pluripotent Stem Cells (iPSCs) by Type

1.2.1 Global Induced Pluripotent Stem Cells (iPSCs) Revenue by Type: 2015 VS 2019 VS 2025

1.2.2 Global Induced Pluripotent Stem Cells (iPSCs) Revenue Market Share by Type in 2019

1.2.3 Human iPSCs

1.2.4 Mouse iPSCs

1.3 Global Induced Pluripotent Stem Cells (iPSCs) Market by Application

1.3.1 Overview: Global Induced Pluripotent Stem Cells (iPSCs) Revenue by Application: 2015 VS 2019 VS 2025

1.3.2 Academic Research

1.3.3 Drug Development and Discovery

1.3.4 Toxicity Screening

1.3.5 Regenerative Medicine

1.3.6 Others

1.4 Global Induced Pluripotent Stem Cells (iPSCs) Market by Regions

1.4.1 Global Induced Pluripotent Stem Cells (iPSCs) Market Size by Regions: 2015 VS 2019 VS 2025

1.4.2 Global Market Size of Induced Pluripotent Stem Cells (iPSCs) (2015-2025)

1.4.3 North America (USA, Canada and Mexico) Induced Pluripotent Stem Cells (iPSCs) Status and Prospect (2015-2025)

1.4.4 Europe (Germany, France, UK, Russia and Italy) Induced Pluripotent Stem Cells (iPSCs) Status and Prospect (2015-2025)

1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Induced Pluripotent Stem Cells (iPSCs) Status and Prospect (2015-2025)

1.4.6 South America (Brazil, Argentina, Colombia) Induced Pluripotent Stem Cells (iPSCs) Status and Prospect (2015-2025)

1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Induced Pluripotent Stem Cells (iPSCs) Status and Prospect (2015-2025)

2 Company Profiles

2.1 Fujifilm Holding Corporation (CDI)

2.1.1 Fujifilm Holding Corporation (CDI) Details

2.1.2 Fujifilm Holding Corporation (CDI) Major Business

2.1.3 Fujifilm Holding Corporation (CDI) SWOT Analysis

2.1.4 Fujifilm Holding Corporation (CDI) Product and Services

2.1.5 Fujifilm Holding Corporation (CDI) Induced Pluripotent Stem Cells (iPSCs) Revenue, Gross Margin and Market Share (2018-2019)

2.2 ReproCELL

2.2.1 ReproCELL Details

2.2.2 ReproCELL Major Business

2.2.3 ReproCELL SWOT Analysis

2.2.4 ReproCELL Product and Services

2.2.5 ReproCELL Induced Pluripotent Stem Cells (iPSCs) Revenue, Gross Margin and Market Share (2018-2019)

2.3 Astellas Pharma Inc

2.3.1 Astellas Pharma Inc Details

2.3.2 Astellas Pharma Inc Major Business

2.3.3 Astellas Pharma Inc SWOT Analysis

2.3.4 Astellas Pharma Inc Product and Services

2.3.5 Astellas Pharma Inc Induced Pluripotent Stem Cells (iPSCs) Revenue, Gross Margin and Market Share (2018-2019)

2.4 Ncardia

2.4.1 Ncardia Details

2.4.2 Ncardia Major Business

2.4.3 Ncardia SWOT Analysis

2.4.4 Ncardia Product and Services

2.4.5 Ncardia Induced Pluripotent Stem Cells (iPSCs) Revenue, Gross Margin and Market Share (2018-2019)

2.5 Cell Inspire Biotechnology

2.5.1 Cell Inspire Biotechnology Details

2.5.2 Cell Inspire Biotechnology Major Business

2.5.3 Cell Inspire Biotechnology SWOT Analysis

2.5.4 Cell Inspire Biotechnology Product and Services

2.5.5 Cell Inspire Biotechnology Induced Pluripotent Stem Cells (iPSCs) Revenue, Gross Margin and Market Share (2018-2019)

2.6 Sumitomo Dainippon Pharma

2.6.1 Sumitomo Dainippon Pharma Details

2.6.2 Sumitomo Dainippon Pharma Major Business

2.6.3 Sumitomo Dainippon Pharma Product and Services

2.6.4 Sumitomo Dainippon Pharma Induced Pluripotent Stem Cells (iPSCs) Revenue, Gross Margin and Market Share (2018-2019)

2.7 Pluricell Biotech

2.7.1 Pluricell Biotech Details

2.7.2 Pluricell Biotech Major Business

2.7.3 Pluricell Biotech Product and Services

2.7.4 Pluricell Biotech Induced Pluripotent Stem Cells (iPSCs) Revenue, Gross Margin and Market Share (2018-2019)

2.8 Fate Therapeutics, Inc

2.8.1 Fate Therapeutics, Inc Details

2.8.2 Fate Therapeutics, Inc Major Business

2.8.3 Fate Therapeutics, Inc Product and Services

2.8.4 Fate Therapeutics, Inc Induced Pluripotent Stem Cells (iPSCs) Revenue, Gross Margin and Market Share (2018-2019)

3 Market Competition, by Players

3.1 Global Induced Pluripotent Stem Cells (iPSCs) Revenue and Share by Players (2015-2020)

3.2 Market Concentration Rate

3.2.1 Top 5 Induced Pluripotent Stem Cells (iPSCs) Players Market Share

3.2.2 Top 10 Induced Pluripotent Stem Cells (iPSCs) Players Market Share

3.3 Market Competition Trend

4 Market Size by Regions

4.1 Global Induced Pluripotent Stem Cells (iPSCs) Revenue and Market Share by Regions

4.2 North America Induced Pluripotent Stem Cells (iPSCs) Revenue and Growth Rate (2015-2020)

4.3 Europe Induced Pluripotent Stem Cells (iPSCs) Revenue and Growth Rate (2015-2020)

4.4 Asia-Pacific Induced Pluripotent Stem Cells (iPSCs) Revenue and Growth Rate (2015-2020)

4.5 South America Induced Pluripotent Stem Cells (iPSCs) Revenue and Growth Rate (2015-2020)

4.6 Middle East & Africa Induced Pluripotent Stem Cells (iPSCs) Revenue and Growth Rate (2015-2020)

5 North America Induced Pluripotent Stem Cells (iPSCs) Revenue by Countries

5.1 North America Induced Pluripotent Stem Cells (iPSCs) Revenue by Countries (2015-2020)

5.2 USA Induced Pluripotent Stem Cells (iPSCs) Revenue and Growth Rate (2015-2020)

5.3 Canada Induced Pluripotent Stem Cells (iPSCs) Revenue and Growth Rate (2015-2020)

5.4 Mexico Induced Pluripotent Stem Cells (iPSCs) Revenue and Growth Rate (2015-2020)

6 Europe Induced Pluripotent Stem Cells (iPSCs) Revenue by Countries

6.1 Europe Induced Pluripotent Stem Cells (iPSCs) Revenue by Countries (2015-2020)

6.2 Germany Induced Pluripotent Stem Cells (iPSCs) Revenue and Growth Rate (2015-2020)

6.3 UK Induced Pluripotent Stem Cells (iPSCs) Revenue and Growth Rate (2015-2020)

6.4 France Induced Pluripotent Stem Cells (iPSCs) Revenue and Growth Rate (2015-2020)

6.5 Russia Induced Pluripotent Stem Cells (iPSCs) Revenue and Growth Rate (2015-2020)

6.6 Italy Induced Pluripotent Stem Cells (iPSCs) Revenue and Growth Rate (2015-2020)

7 Asia-Pacific Induced Pluripotent Stem Cells (iPSCs) Revenue by Countries

7.1 Asia-Pacific Induced Pluripotent Stem Cells (iPSCs) Revenue by Countries (2015-2020)

7.2 China Induced Pluripotent Stem Cells (iPSCs) Revenue and Growth Rate (2015-2020)

7.3 Japan Induced Pluripotent Stem Cells (iPSCs) Revenue and Growth Rate (2015-2020)

7.4 Korea Induced Pluripotent Stem Cells (iPSCs) Revenue and Growth Rate (2015-2020)

7.5 India Induced Pluripotent Stem Cells (iPSCs) Revenue and Growth Rate (2015-2020)

7.6 Southeast Asia Induced Pluripotent Stem Cells (iPSCs) Revenue and Growth Rate (2015-2020)

8 South America Induced Pluripotent Stem Cells (iPSCs) Revenue by Countries

8.1 South America Induced Pluripotent Stem Cells (iPSCs) Revenue by Countries (2015-2020)

8.2 Brazil Induced Pluripotent Stem Cells (iPSCs) Revenue and Growth Rate (2015-2020)

8.3 Argentina Induced Pluripotent Stem Cells (iPSCs) Revenue and Growth Rate (2015-2020)

9 Middle East & Africa Revenue Induced Pluripotent Stem Cells (iPSCs) by Countries

9.1 Middle East & Africa Induced Pluripotent Stem Cells (iPSCs) Revenue by Countries (2015-2020)

9.2 Saudi Arabia Induced Pluripotent Stem Cells (iPSCs) Revenue and Growth Rate (2015-2020)

9.3 UAE Induced Pluripotent Stem Cells (iPSCs) Revenue and Growth Rate (2015-2020)

9.4 Egypt Induced Pluripotent Stem Cells (iPSCs) Revenue and Growth Rate (2015-2020)

9.5 South Africa Induced Pluripotent Stem Cells (iPSCs) Revenue and Growth Rate (2015-2020)

10 Market Size Segment by Type

10.1 Global Induced Pluripotent Stem Cells (iPSCs) Revenue and Market Share by Type (2015-2020)

10.2 Global Induced Pluripotent Stem Cells (iPSCs) Market Forecast by Type (2019-2024)

10.3 Human iPSCs Revenue Growth Rate (2015-2025)

10.4 Mouse iPSCs Revenue Growth Rate (2015-2025)

11 Global Induced Pluripotent Stem Cells (iPSCs) Market Segment by Application

11.1 Global Induced Pluripotent Stem Cells (iPSCs) Revenue Market Share by Application (2015-2020)

11.2 Induced Pluripotent Stem Cells (iPSCs) Market Forecast by Application (2019-2024)

11.3 Academic Research Revenue Growth (2015-2020)

11.4 Drug Development and Discovery Revenue Growth (2015-2020)

11.5 Toxicity Screening Revenue Growth (2015-2020)

11.6 Regenerative Medicine Revenue Growth (2015-2020)

11.7 Others Revenue Growth (2015-2020)

12 Global Induced Pluripotent Stem Cells (iPSCs) Market Size Forecast (2021-2025)

12.1 Global Induced Pluripotent Stem Cells (iPSCs) Market Size Forecast (2021-2025)

12.2 Global Induced Pluripotent Stem Cells (iPSCs) Market Forecast by Regions (2021-2025)

12.3 North America Induced Pluripotent Stem Cells (iPSCs) Revenue Market Forecast (2021-2025)

12.4 Europe Induced Pluripotent Stem Cells (iPSCs) Revenue Market Forecast (2021-2025)

12.5 Asia-Pacific Induced Pluripotent Stem Cells (iPSCs) Revenue Market Forecast (2021-2025)

12.6 South America Induced Pluripotent Stem Cells (iPSCs) Revenue Market Forecast (2021-2025)

12.7 Middle East & Africa Induced Pluripotent Stem Cells (iPSCs) Revenue Market Forecast (2021-2025)

13 Research Findings and Conclusion

14 Appendix

14.1 Methodology

14.2 Data Source

14.3 Disclaimer

14.4 About US

List of Tables

Table 1. Global Induced Pluripotent Stem Cells (iPSCs) Revenue (USD Million) by Type: 2015 VS 2019 VS 2025

Table 2. Breakdown of Induced Pluripotent Stem Cells (iPSCs) by Company Type (Tier 1, Tier 2 and Tier 3)

Table 3. Global Induced Pluripotent Stem Cells (iPSCs) Revenue (USD Million) by Application: 2015 VS 2019 VS 2025

Table 4. Global Market Induced Pluripotent Stem Cells (iPSCs) Revenue (Million USD) Comparison by Regions 2015-2025

Table 5. Global Induced Pluripotent Stem Cells (iPSCs) Market Size and Growth Estimation in Various Scenarios in 2020

Table 6. Fujifilm Holding Corporation (CDI) Corporate Information, Location and Competitors

Table 7. Fujifilm Holding Corporation (CDI) Induced Pluripotent Stem Cells (iPSCs) Major Business

Table 8. Fujifilm Holding Corporation (CDI) Induced Pluripotent Stem Cells (iPSCs) Total Revenue (USD Million) (2017-2018)

Table 9. Fujifilm Holding Corporation (CDI) SWOT Analysis

Table 10. Fujifilm Holding Corporation (CDI) Induced Pluripotent Stem Cells (iPSCs) Product and Solutions

Table 11. Fujifilm Holding Corporation (CDI) Induced Pluripotent Stem Cells (iPSCs) Revenue (USD Million), Gross Margin and Market Share (2018-2019)

Table 12. ReproCELL Corporate Information, Location and Competitors

Table 13. ReproCELL Induced Pluripotent Stem Cells (iPSCs) Major Business

Table 14. ReproCELL Induced Pluripotent Stem Cells (iPSCs) Total Revenue (USD Million) (2018-2019)

Table 15. ReproCELL SWOT Analysis

Table 16. ReproCELL Induced Pluripotent Stem Cells (iPSCs) Product and Solutions

Table 17. ReproCELL Induced Pluripotent Stem Cells (iPSCs) Revenue (USD Million), Gross Margin and Market Share (2018-2019)

Table 18. Astellas Pharma Inc Corporate Information, Location and Competitors

Table 19. Astellas Pharma Inc Induced Pluripotent Stem Cells (iPSCs) Major Business

Table 20. Astellas Pharma Inc Induced Pluripotent Stem Cells (iPSCs) Total Revenue (USD Million) (2017-2018)

Table 21. Astellas Pharma Inc SWOT Analysis

Table 22. Astellas Pharma Inc Induced Pluripotent Stem Cells (iPSCs) Product and Solutions

Table 23. Astellas Pharma Inc Induced Pluripotent Stem Cells (iPSCs) Revenue (USD Million), Gross Margin and Market Share (2018-2019)

Table 24. Ncardia Corporate Information, Location and Competitors

Table 25. Ncardia Induced Pluripotent Stem Cells (iPSCs) Major Business

Table 26. Ncardia Induced Pluripotent Stem Cells (iPSCs) Total Revenue (USD Million) (2017-2018)

Table 27. Ncardia SWOT Analysis

Table 28. Ncardia Induced Pluripotent Stem Cells (iPSCs) Product and Solutions

Table 29. Ncardia Induced Pluripotent Stem Cells (iPSCs) Revenue (USD Million), Gross Margin and Market Share (2018-2019)

Table 30. Cell Inspire Biotechnology Corporate Information, Location and Competitors

Table 31. Cell Inspire Biotechnology Induced Pluripotent Stem Cells (iPSCs) Major Business

Table 32. Cell Inspire Biotechnology Induced Pluripotent Stem Cells (iPSCs) Total Revenue (USD Million) (2017-2018)

Table 33. Cell Inspire Biotechnology SWOT Analysis

Table 34. Cell Inspire Biotechnology Induced Pluripotent Stem Cells (iPSCs) Product and Solutions

Table 35. Cell Inspire Biotechnology Induced Pluripotent Stem Cells (iPSCs) Revenue (USD Million), Gross Margin and Market Share (2018-2019)

Table 36. Sumitomo Dainippon Pharma Corporate Information, Location and Competitors

Table 37. Sumitomo Dainippon Pharma Induced Pluripotent Stem Cells (iPSCs) Major Business

Table 38. Sumitomo Dainippon Pharma Induced Pluripotent Stem Cells (iPSCs) Total Revenue (USD Million) (2017-2018)

Table 39. Sumitomo Dainippon Pharma SWOT Analysis

Table 40. Sumitomo Dainippon Pharma Induced Pluripotent Stem Cells (iPSCs) Product and Solutions

Table 41. Sumitomo Dainippon Pharma Induced Pluripotent Stem Cells (iPSCs) Revenue (USD Million), Gross Margin and Market Share (2018-2019)

Table 42. Pluricell Biotech Corporate Information, Location and Competitors

Table 43. Pluricell Biotech Induced Pluripotent Stem Cells (iPSCs) Major Business

Table 44. Pluricell Biotech Induced Pluripotent Stem Cells (iPSCs) Total Revenue (USD Million) (2017-2018)

Table 45. Pluricell Biotech SWOT Analysis

Table 46. Pluricell Biotech Induced Pluripotent Stem Cells (iPSCs) Product and Solutions

Table 47. Pluricell Biotech Induced Pluripotent Stem Cells (iPSCs) Revenue (USD Million), Gross Margin and Market Share (2018-2019)

Table 48. Fate Therapeutics, Inc Corporate Information, Location and Competitors

Table 49. Fate Therapeutics, Inc Induced Pluripotent Stem Cells (iPSCs) Major Business

Table 50. Fate Therapeutics, Inc Induced Pluripotent Stem Cells (iPSCs) Total Revenue (USD Million) (2017-2018)

Table 51. Fate Therapeutics, Inc SWOT Analysis

Table 52. Fate Therapeutics, Inc Induced Pluripotent Stem Cells (iPSCs) Product and Solutions

Table 53. Fate Therapeutics, Inc Induced Pluripotent Stem Cells (iPSCs) Revenue (USD Million), Gross Margin and Market Share (2018-2019)

Table 54. Global Induced Pluripotent Stem Cells (iPSCs) Revenue (Million USD) by Players (2015-2020)

Table 55. Global Induced Pluripotent Stem Cells (iPSCs) Revenue Share by Players (2015-2020)

Table 56. Global Induced Pluripotent Stem Cells (iPSCs) Revenue (Million USD) by Regions (2015-2020)

Table 57. Global Induced Pluripotent Stem Cells (iPSCs) Revenue Market Share by Regions (2015-2020)

Table 58. North America Induced Pluripotent Stem Cells (iPSCs) Revenue by Countries (2015-2020)

Table 59. North America Induced Pluripotent Stem Cells (iPSCs) Revenue Market Share by Countries (2015-2020)

Table 60. Europe Induced Pluripotent Stem Cells (iPSCs) Revenue (Million USD) by Countries (2015-2020)

Table 61. Asia-Pacific Induced Pluripotent Stem Cells (iPSCs) Revenue (Million USD) by Countries (2015-2020)

Table 62. South America Induced Pluripotent Stem Cells (iPSCs) Revenue by Countries (2015-2020)

Table 63. South America Induced Pluripotent Stem Cells (iPSCs) Revenue Market Share by Countries (2015-2020)

Table 64. Middle East and Africa Induced Pluripotent Stem Cells (iPSCs) Revenue (Million USD) by Countries (2015-2020)

Table 65. Middle East and Africa Induced Pluripotent Stem Cells (iPSCs) Revenue Market Share by Countries (2015-2020)

Table 66. Global Induced Pluripotent Stem Cells (iPSCs) Revenue (Million USD) by Type (2015-2020)

Table 67. Global Induced Pluripotent Stem Cells (iPSCs) Revenue Share by Type (2015-2020)

Table 68. Global Induced Pluripotent Stem Cells (iPSCs) Revenue Forecast by Type (2021-2025)

Table 69. Global Induced Pluripotent Stem Cells (iPSCs) Revenue by Application (2015-2020)

Table 70. Global Induced Pluripotent Stem Cells (iPSCs) Revenue Share by Application (2015-2020)

Table 71. Global Induced Pluripotent Stem Cells (iPSCs) Revenue Forecast by Application (2021-2025)

Table 72. Global Induced Pluripotent Stem Cells (iPSCs) Revenue (Million USD) Forecast by Regions (2021-2025)

List of Figures

Figure 1. Induced Pluripotent Stem Cells (iPSCs) Picture

Figure 2. Global Induced Pluripotent Stem Cells (iPSCs) Revenue Market Share by Type in 2019

Figure 3. Human iPSCs Picture

Figure 4. Mouse iPSCs Picture

Figure 5. Induced Pluripotent Stem Cells (iPSCs) Revenue Market Share by Application in 2019

Figure 6. Academic Research Picture

Figure 7. Drug Development and Discovery Picture

Figure 8. Toxicity Screening Picture

Figure 9. Regenerative Medicine Picture

Figure 10. Others Picture

Figure 11. Global Induced Pluripotent Stem Cells (iPSCs) Revenue (USD Million) and Growth Rate (2015-2025)

Figure 12. North America Induced Pluripotent Stem Cells (iPSCs) Revenue (Million USD) and Growth Rate (2015-2025)

Figure 13. Europe Induced Pluripotent Stem Cells (iPSCs) Revenue (Million USD) and Growth Rate (2015-2025)

Figure 14. Asia-Pacific Induced Pluripotent Stem Cells (iPSCs) Revenue (Million USD) and Growth Rate (2015-2025)

Figure 15. South America Induced Pluripotent Stem Cells (iPSCs) Revenue (Million USD) and Growth Rate (2015-2025)

Figure 16. Middle East and Africa Induced Pluripotent Stem Cells (iPSCs) Revenue (Million USD) and Growth Rate (2015-2025)

Figure 17. Global Induced Pluripotent Stem Cells (iPSCs) Revenue (Million USD) and Growth Rate (2015-2025)

Figure 18. Global Induced Pluripotent Stem Cells (iPSCs) Revenue Share by Players in 2019

Figure 19. Global Top 5 Players Induced Pluripotent Stem Cells (iPSCs) Revenue Market Share in 2019

Figure 20. Global Top 10 Players Induced Pluripotent Stem Cells (iPSCs) Revenue Market Share in 2019

Figure 21. Key Players Market Share Trend

Figure 22. Global Induced Pluripotent Stem Cells (iPSCs) Revenue (Million USD) and Growth Rate (%) (2015-2020)

Figure 23. Global Induced Pluripotent Stem Cells (iPSCs) Revenue Market Share by Regions (2015-2020)

Figure 24. Global Induced Pluripotent Stem Cells (iPSCs) Revenue Market Share by Regions in 2018

Figure 25. North America Induced Pluripotent Stem Cells (iPSCs) Revenue and Growth Rate (2015-2020)

Figure 26. Europe Induced Pluripotent Stem Cells (iPSCs) Revenue and Growth Rate (2015-2020)

Figure 27. Asia-Pacific Induced Pluripotent Stem Cells (iPSCs) Revenue and Growth Rate (2015-2020)

Figure 28. South America Induced Pluripotent Stem Cells (iPSCs) Revenue and Growth Rate (2015-2020)

Figure 29. Middle East and Africa Induced Pluripotent Stem Cells (iPSCs) Revenue and Growth Rate (2015-2020)

Figure 30. North America Induced Pluripotent Stem Cells (iPSCs) Revenue Market Share by Countries (2015-2020)

Figure 31. North America Induced Pluripotent Stem Cells (iPSCs) Revenue Market Share by Countries in 2019

Figure 32. USA Induced Pluripotent Stem Cells (iPSCs) Revenue and Growth Rate (2015-2020)

Figure 33. Canada Induced Pluripotent Stem Cells (iPSCs) Revenue and Growth Rate (2015-2020)

Figure 34. Mexico Induced Pluripotent Stem Cells (iPSCs) Revenue and Growth Rate (2015-2020)

Figure 35. Europe Induced Pluripotent Stem Cells (iPSCs) Revenue Market Share by Countries (2015-2020)

Figure 36. Europe Induced Pluripotent Stem Cells (iPSCs) Revenue Market Share by Countries in 2019

Figure 37. Germany Induced Pluripotent Stem Cells (iPSCs) Revenue and Growth Rate (2015-2020)

Figure 38. UK Induced Pluripotent Stem Cells (iPSCs) Revenue and Growth Rate (2015-2020)

Figure 39. France Induced Pluripotent Stem Cells (iPSCs) Revenue and Growth Rate (2015-2020)

Figure 40. Russia Induced Pluripotent Stem Cells (iPSCs) Revenue and Growth Rate (2015-2020)

Figure 41. Italy Induced Pluripotent Stem Cells (iPSCs) Revenue and Growth Rate (2015-2020)

Figure 42. Asia-Pacific Induced Pluripotent Stem Cells (iPSCs) Revenue Market Share by Countries (2015-2020)

Figure 43. Asia-Pacific Induced Pluripotent Stem Cells (iPSCs) Revenue Market Share by Countries in 2019

Figure 44. China Induced Pluripotent Stem Cells (iPSCs) Revenue and Growth Rate (2015-2020)

Figure 45. Japan Induced Pluripotent Stem Cells (iPSCs) Revenue and Growth Rate (2015-2020)

Figure 46. Korea Induced Pluripotent Stem Cells (iPSCs) Revenue and Growth Rate (2015-2020)

Figure 47. India Induced Pluripotent Stem Cells (iPSCs) Revenue and Growth Rate (2015-2020)

Figure 48. Southeast Asia Induced Pluripotent Stem Cells (iPSCs) Revenue and Growth Rate (2015-2020)

Figure 49. South America Induced Pluripotent Stem Cells (iPSCs) Revenue Market Share by Countries (2015-2020)

Figure 50. South America Induced Pluripotent Stem Cells (iPSCs) Revenue Market Share by Countries in 2019

Figure 51. Brazil Induced Pluripotent Stem Cells (iPSCs) Revenue and Growth Rate (2015-2020)

Figure 52. Argentina Induced Pluripotent Stem Cells (iPSCs) Revenue and Growth Rate (2015-2020)

Figure 53. Middle East and Africa Induced Pluripotent Stem Cells (iPSCs) Revenue Market Share by Countries (2015-2020)

Figure 54. Middle East and Africa Induced Pluripotent Stem Cells (iPSCs) Revenue Market Share by Countries in 2019

Figure 55. Saudi Arabia Induced Pluripotent Stem Cells (iPSCs) Revenue and Growth Rate (2015-2020)

Figure 56. UAE Induced Pluripotent Stem Cells (iPSCs) Revenue and Growth Rate (2015-2020)

Figure 57. Egypt Induced Pluripotent Stem Cells (iPSCs) Revenue and Growth Rate (2015-2020)

Figure 58. South Africa Induced Pluripotent Stem Cells (iPSCs) Revenue and Growth Rate (2015-2020)

Figure 59. Global Induced Pluripotent Stem Cells (iPSCs) Revenue Share by Type (2015-2020)

Figure 60. Global Induced Pluripotent Stem Cells (iPSCs) Revenue Share by Type in 2019

Figure 61. Global Induced Pluripotent Stem Cells (iPSCs) Market Share Forecast by Type (2021-2025)

Figure 62. Global Human iPSCs Revenue Growth Rate (2015-2020)

Figure 63. Global Mouse iPSCs Revenue Growth Rate (2015-2020)

Figure 64. Global Induced Pluripotent Stem Cells (iPSCs) Revenue Share by Application (2015-2020)

Figure 65. Global Induced Pluripotent Stem Cells (iPSCs) Revenue Share by Application in 2019

Figure 66. Global Induced Pluripotent Stem Cells (iPSCs) Market Share Forecast by Application (2021-2025)

Figure 67. Global Academic Research Revenue Growth Rate (2015-2020)

Figure 68. Global Drug Development and Discovery Revenue Growth Rate (2015-2020)

Figure 69. Global Toxicity Screening Revenue Growth Rate (2015-2020)

Figure 70. Global Regenerative Medicine Revenue Growth Rate (2015-2020)

Figure 71. Global Others Revenue Growth Rate (2015-2020)

Figure 72. Global Induced Pluripotent Stem Cells (iPSCs) Revenue (Million USD) and Growth Rate Forecast (2021-2025)

Figure 73. Global Induced Pluripotent Stem Cells (iPSCs) Revenue (Million USD) Forecast by Regions (2021-2025)

Figure 74. Global Induced Pluripotent Stem Cells (iPSCs) Revenue Market Share Forecast by Regions (2021-2025)

Figure 75. North America Induced Pluripotent Stem Cells (iPSCs) Revenue Market Forecast (2021-2025)

Figure 76. Europe Induced Pluripotent Stem Cells (iPSCs) Revenue Market Forecast (2021-2025)

Figure 77. Asia-Pacific Induced Pluripotent Stem Cells (iPSCs) Revenue Market Forecast (2021-2025)

Figure 78. South America Induced Pluripotent Stem Cells (iPSCs) Revenue Market Forecast (2021-2025)

Figure 79. Middle East and Africa Induced Pluripotent Stem Cells (iPSCs) Revenue Market Forecast (2021-2025)

Figure 80. Sales Channel: Direct Channel vs Indirect Channel

shopping_cart License Type

Buy Now

email Quick Contact

+1

tag_faces Our Clients

help Need Help?

Please contact directly on our US and India numbers

+1-201-465-4211

Please feel free to write an email to us or to use our electronic ticketing system.

sales@marketquest.biz